Kendall Burnett

  • 99 Bishopsgate
  • London EC2M 3XF
  • United Kingdom
Profile Experience

Kendall Burnett is an associate in the London office of Latham & Watkins and a member of the Benefits, Compensation & Employment Practice. Ms. Burnett's practice focuses on all aspects of employment, remuneration, and incentives matters, including international aspects of share based incentivization and related employment and corporate governance issues.

She is a member of the Employment Lawyers Association and Share Plan Lawyers Group.

  • Cross-border acquisitions
  • Recruitment and severance
  • Transfer of undertakings
  • Downsizing
  • Share-based incentivization
  • Corporate governance

Ms. Burnett's experience includes advising:

  • ESR Cayman Limited on its US$1.6 billion IPO
  • A consortium led by Blackstone and CVC Capital Partners on its £2.96 billion offer for Paysafe Group plc, a leading global provider of end to end payment solutions, the deal represents the largest public-to-private deal under the UK Takeover Code since 2010
  • TI Fluid Systems plc on its £1.3 billion initial public offering on the London Stock Exchange
  • The sellers on the disposal of Method and Ecover to US private company SC Johnson
  • Leonard Green & Partners on its acquisition of Pure Gym
  • The Carlyle Group and The Nature’s Bounty Co. on the £1.77 billion sale of Holland & Barrett, one of Europe’s largest health and wellness retailers
  • A UK restaurant chain in negotiating the exit of its CEO
  • On the dual listing of LivaNova PLC, a medical device company, on the London Stock Exchange and NASDAQ on the closing of the merger between Cyberonics, Inc. and Sorin S.p.A
  • The Carlyle Group in its US$4.15 billion acquisition from Johnson & Johnson of Ortho-Clinical Diagnostics, a global provider of solutions for screening and confirming diseases
  • Expedia in its acquisition of a majority stake in SilverRail Technologies
  • RPC in connection with its acquisition of Promens, an Iceland-based provider of rigid plastic packaging to the food and non-food, consumer, and industrial markets
  • The Cooper Companies in connection with its US$1.256 billion acquisition of Sauflon Pharmaceuticals, a UK-based manufacturer and distributor of contact lenses and contact solutions
Notice: We appreciate your interest in Latham & Watkins. If your inquiry relates to a legal matter and you are not already a current client of the firm, please do not transmit any confidential information to us. Before taking on a representation, we must determine whether we are in a position to assist you and agree on the terms and conditions of engagement with you. Until we have completed such steps, we will not be deemed to have a lawyer-client relationship with you, and will have no duty to keep confidential the information we receive from you. Thank you for your understanding.